Evaluation of the Clinical Specificity of Cellular and Molecular Biomarkers Identified in Patients With Lichen Planus

Status: Recruiting
Location: See all (6) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Lichen planus (LP) is a chronic inflammatory disease of unknown aetiology, affecting the skin and mucous membranes, characterised by a CD8+ cytotoxic T-cell infiltrate, associated with epithelial cell death and disruption of the basement membrane zone. In previous work, T cell antigen receptor (TCR) repertoire studies were performed. In all patients tested, whether with erosive or non-erosive LP, unique nucleotide sequences, called clonotypes, have been identified. They appear during the process of TCR gene rearrangement. These clonotypes are specific for human papillomavirus (HPV) in blood and lesions, suggesting antigenic stimulation of these clonotypes by a viral epitope of HPV, which crosses with an epitope on keratinocytes. The diagnosis of LP is made on the basis of clinical and histological criteria, but in some patients and in some anatomical locations, the diagnosis is difficult to make and LP may be confused with other skin conditions.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Subject coming at the time of diagnosis of the disease before any systemic treatment, or at the time of a progressive episode of the disease, without systemic treatment or after cessation of immunomodulatory or immunosuppressive treatment

• Ability to give their consent in writing

• Must understand spoken and written French

• Affiliated to the French social security or assimilated regimes

Locations
Other Locations
France
CHU de Besançon
RECRUITING
Besançon
CHU Paris Seine-Saint-Denis- Hôpital Avicenne
RECRUITING
Bobigny
Centre Medical de l'Institut Pasteur
RECRUITING
Paris
Hôpital Saint-Louis
RECRUITING
Paris
Hôpital Robert Debré, CHU de Reims
RECRUITING
Reims
CHU de Rouen
RECRUITING
Rouen
Contact Information
Primary
Marie-Lise Gougeon
marie-lise.gougeon@pasteur.fr
1 40 66 97 87
Backup
Sandrine Fernandes Pellerin
sandrine.fernandes-pellerin@pasteur.fr
1 45 68 81 79
Time Frame
Start Date: 2023-11-01
Estimated Completion Date: 2027-04-30
Participants
Target number of participants: 70
Treatments
Experimental: Oral lichen planus erosive
Human biological samples :~* blood samples collection at visit 1 and 2 (6 month after first visit)~* brushing on skin or mucous membrane lesions at visit 1~* skin or mucous membrane biopsy at visit 1 and 2
Experimental: mucosal pemphigoid with oral lesions
Human biological samples :~* blood samples collection at visit 1~* brushing on skin or mucous membrane lesions at visit 1
Experimental: lichen planus with scalp involvement
Human biological samples :~* blood samples collection at visit 1~* brushing on skin or mucous membrane lesions at visit 1
Experimental: Pseudopelade of Brocq
Human biological samples :~* blood samples collection at visit 1~* brushing on skin or mucous membrane lesions at visit 1~* skin or mucous membrane biopsy at visit 1
Experimental: lichen planus with nail involvement
Human biological samples :~* blood samples collection at visit 1~* brushing on skin or mucous membrane lesions at visit 1
Experimental: psoriasis and specific nail involvement
Human biological samples :~* blood samples collection at visit 1~* brushing on skin or mucous membrane lesions at visit 1
Experimental: Lichenoid graft-versus-host disease
Human biological samples :~* blood samples collection at visit 1~* brushing on skin or mucous membrane lesions at visit 1
Related Therapeutic Areas
Sponsors
Leads: Institut Pasteur

This content was sourced from clinicaltrials.gov

Similar Clinical Trials